(Common Stock)
Investor Relations
Aduro is an immunotherapy company focused on the discovery, development and commercialization of therapies that transform the treatment of challenging diseases. Aduro's technologies, which are designed to harness the body's natural immune system, are being investigated in multiple diseases including cancer, kidney, autoimmune and infectious disease.